Atara Biotherapeutics Inc T-Cell Operations and Manufacturing (ATOM) Facility Acquisition by FUJIFILM Diosynth Biotechnologies (FDB) Transcript
Good afternoon, everyone. Thank you for standing by, and welcome to the Atara Biotherapeutics Conference Call. (Operator Instructions) Please be advised that today's call is being recorded. I'd now like to hand the call over to Eric Hyllengren, Vice President of Investor Relations and Finance at Atara Biotherapeutics. Please go ahead, sir.
Thank you, operator. Good afternoon, everyone, and welcome to Atara's strategic Manufacturing Partnership Conference Call. Earlier today, we issued a press release announcing that we entered into a strategic manufacturing partnership with Fujifilm. This is an exciting partnership for both Atara and Fujifilm, and the press release and slides are available in the Investors & Media section at atarabio.com.
On today's call, we will provide an overview of the partnership, including the strategic rationale, as well as additional details of the transaction. Joining me on today's call are Dr. Pascal Touchon, President and Chief Executive Officer; Dr.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
